Image

A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Join a study for treating moderate to severe eczema.

Recruiting
18 years and older
All
Phase 2

This study examines how well a new drug, JNJ-95475939, helps people with moderate to severe atopic dermatitis (AD), a chronic skin condition causing itchy, inflamed skin. It compares the drug to a placebo, a harmless pill with no active medicine, to see if the drug is effective. Participants should have had AD symptoms for at least a year before the study starts, and their condition must be quite severe, with a high score on tests measuring eczema and itching. They should have tried other treatments without success.

  • The study involves regular visits to the clinic for monitoring.
  • Participants should not be pregnant or breastfeeding.
  • Potential risks include reactions if they have certain skin or health conditions.

Participants should not have other active skin diseases or infections that could interfere with the study. Also, they cannot have had major surgery recently. This study will help understand if JNJ-95475939 could be a new treatment option for those who haven't found relief with other therapies.

Study details
    Dermatitis
    Atopic

NCT06881251

Janssen Research & Development, LLC

31 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.